Researchers from UC San Francisco and the Chan Zuckerberg Biohub (CZ Biohub) have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals. This type ...
Dec 7, 2020
0
68
The highest concentration of adverse birth outcomes and related maternal risk factors occur in rural areas of Alberta with the lowest socioeconomic status, according to new research from the University of Alberta.
Sep 10, 2020
0
0
New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe ...
Aug 5, 2020
0
4
(HealthDay)—Over a lifetime, women who've had a preterm delivery have a higher risk of heart disease, new research suggests.
Jun 29, 2020
0
2
Immune system cells in the blood of breast cancer patients undergo alterations early in the disease course, according to a study published in the journal Clinical & Translational Immunology. The authors believe that this ...
May 13, 2020
0
61
New York City's death toll from the coronavirus may be thousands of fatalities worse than the tally kept by the city and state, according to an analysis released Monday by the U.S. Centers for Disease Control and Prevention.
May 11, 2020
0
1054
Even though mortality from congenital heart disease (CHD) has declined over the last three decades as diagnosis and treatments have advanced, the chances for a child to survive a CHD diagnosis significantly differs based ...
Jan 31, 2020
0
4
(HealthDay)—Blood pressure (BP) measures progress more rapidly in women than in men, starting in the third decade and continuing through the life course, according to a study published online Jan. 15 in JAMA Cardiology.
Jan 15, 2020
0
1
A prospective study recently published in the journal Cephalalgia, the official journal of the International Headache Society, extends the idea behind cluster headache chronicity. The study, entitled "Temporal changes of ...
Jan 2, 2020
0
8
In the last five years, the landscape of type 2 diabetes treatment has changed dramatically. Two new classes of drugs—SGLT2 inhibitors and GLP-1 receptor agonists—have been shown to prevent some of the most serious diabetes ...
Oct 23, 2019
0
2
